§45C. Clinical testing expenses for certain drugs for rare diseases or conditions — Inbound Citations
26 U.S.C. § 45C
Cited by 8 provisions in release 119-102.
Citations to 26 U.S.C. § 45C as a whole
-
(1) No deduction shall be allowed for that portion of the qualified clinical testing expenses (as defined in section 45C(b)) otherwise allowable as a deduction for the taxable year which is equal to the amount of the credit allowable for the taxable year under section 45C (determined without regard to section 38(c)).
-
(A) the amount of the credit allowable for the taxable year under section 45C (determined without regard to section 38(c)), exceeds
-
(D) section 45C (clinical testing expenses for certain drugs for rare diseases or conditions),
Citations to §45C(a)
-
(12) the orphan drug credit determined under section 45C(a),
-
(ii) the amount of the credit under section 45C(a) shall be the amount determined under subparagraph (B).
-
(i) the amount of credit determined under section 45C(a) without regard to this paragraph, over
Citations to §45C(b)
-
(1) No deduction shall be allowed for that portion of the qualified clinical testing expenses (as defined in section 45C(b)) otherwise allowable as a deduction for the taxable year which is equal to the amount of the credit allowable for the taxable year under section 45C (determined without regard to section 38(c)).
Citations to §45C(d)(4)
-
(m) The period for assessing a deficiency attributable to any election under section 30B(h)(9), 30C(e)(4), 30D(f)(6), 35(g)(11), 40(f), 43, 45B, 45C(d)(4), 45H(g), or 51(j) (or any revocation thereof) shall not expire before the date 1 year after the date on which the Secretary is notified of such election (or revocation).